Key result
Rotarix vaccine introduction shows no impact on antigenic amino acid differences in post-vaccine G1P[8] strains.
Observational (n=103)
Whole-genome analysis indicates that the introduction of the Rotarix vaccine in South Africa did not significantly drive amino acid changes in the antigenic regions of G1P[8] rotavirus strains.
Rotarix introduction shows no antigenic changes in G1P[8] strains; leaves open need for ongoing genomic surveillance in vaccinated populations.
Rotavirus G1P[8] strains account for more than half of the group A rotavirus (RVA) infections in children under five years of age, globally. A total of 103 stool samples previously characterized as G1P[8] and collected seven years before and seven years after introducing the Rotarix® vaccine in South Africa were processed for whole-genome sequencing. All the strains analyzed had a Wa-like constellation (G1-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1). South African pre- and post-vaccine G1 strains were clustered in G1 lineage-I and II while the majority (84.2%) of the P[8] strains were grouped in P[8] lineage-III. Several amino acid sites across ten gene segments with the exception of VP7 were under positive selective pressure. Except for the N147D substitution in the antigenic site of eight post-vaccine G1 strains when compared to both Rotarix® and pre-vaccine strains, most of the amino acid substitutions in the antigenic regions of post-vaccine G1P[8] strains were already present during the pre-vaccine period. Therefore, Rotarix® did not appear to have an impact on the amino acid differences in the antigenic regions of South African post-vaccine G1P[8] strains. However, continued whole-genome surveillance of RVA strains to decipher genetic changes in the post-vaccine period remains imperative.
No takes yet. Share an insight, caveat, or question.
Mwangi et al. (2020) conducted an observational in Rotavirus G1P[8] infection (n=103). Rotarix vaccine vs. Pre-vaccine strains was evaluated on Whole-genome sequence genetic changes and amino acid substitutions. Rotarix vaccine introduction did not impact amino acid differences in the antigenic regions of post-vaccine G1P[8] strains, with 84.2% of P[8] strains grouping in lineage-III.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: